Trellus Health plc
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated… Read more
Trellus Health plc (TRLS) - Net Assets
Latest net assets as of June 2025: GBX8.71 Million GBX
Based on the latest financial reports, Trellus Health plc (TRLS) has net assets worth GBX8.71 Million GBX as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX9.22 Million) and total liabilities (GBX513.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX8.71 Million |
| % of Total Assets | 94.44% |
| Annual Growth Rate | 29.02% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 329.59 |
Trellus Health plc - Net Assets Trend (2020–2024)
This chart illustrates how Trellus Health plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Trellus Health plc (2020–2024)
The table below shows the annual net assets of Trellus Health plc from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX11.77 Million | -39.66% |
| 2023-12-31 | GBX19.50 Million | -22.28% |
| 2022-12-31 | GBX25.09 Million | -28.87% |
| 2021-12-31 | GBX35.27 Million | +730.76% |
| 2020-12-31 | GBX4.25 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Trellus Health plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2883300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX137.00K | 1.16% |
| Other Comprehensive Income | GBX-2.16 Million | -18.37% |
| Other Components | GBX43.39 Million | 368.72% |
| Total Equity | GBX11.77 Million | 100.00% |
Trellus Health plc Competitors by Market Cap
The table below lists competitors of Trellus Health plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HONEYWELL FLOUR MILL PLC
XNSA:HONYFLOUR
|
$120.75 |
|
Egyptian Kuwaiti Holding
EGX:EKHO
|
$121.07 |
|
Raslag Corp.
PSE:ASLAG
|
$121.10 |
|
SHENGLI OIL & GAS
MU:GSG
|
$121.21 |
|
Pelayaran Jaya Hidup Baru Tbk
JK:PJHB
|
$120.61 |
|
E.A.CABLES LTD
XNAI:EACABLES
|
$120.45 |
|
Cv Holdings Inc
PINK:CVHL
|
$120.42 |
|
Adheris Health Limited
AU:AHE
|
$119.94 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Trellus Health plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 19,501,000 to 11,767,000, a change of -7,734,000 (-39.7%).
- Net loss of 7,782,000 reduced equity.
- Other comprehensive income increased equity by 48,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-7.78 Million | -66.13% |
| Other Comprehensive Income | GBX48.00K | +0.41% |
| Total Change | GBX- | -39.66% |
Book Value vs Market Value Analysis
This analysis compares Trellus Health plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.46x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 6.43x to 4.46x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | GBX0.05 | GBX0.33 | x |
| 2021-12-31 | GBX0.27 | GBX0.33 | x |
| 2022-12-31 | GBX0.16 | GBX0.33 | x |
| 2023-12-31 | GBX0.12 | GBX0.33 | x |
| 2024-12-31 | GBX0.07 | GBX0.33 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Trellus Health plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -66.13%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -6826.32%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 1.03x
- Recent ROE (-66.13%) is below the historical average (-37.28%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -35.89% | 0.00% | 0.00x | 1.03x | GBX-1.95 Million |
| 2021 | -16.73% | -23608.00% | 0.00x | 1.04x | GBX-9.43 Million |
| 2022 | -35.11% | -48944.44% | 0.00x | 1.03x | GBX-11.32 Million |
| 2023 | -32.51% | -33363.16% | 0.00x | 1.04x | GBX-8.29 Million |
| 2024 | -66.13% | -6826.32% | 0.01x | 1.03x | GBX-8.96 Million |
Industry Comparison
This section compares Trellus Health plc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $29,054,893
- Average return on equity (ROE) among peers: -68.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Trellus Health plc (TRLS) | GBX8.71 Million | -35.89% | 0.06x | $120.63 |
| Cambridge Cognition Holdings Plc (COG) | $2.13 Million | -134.32% | 0.77x | $2.46K |
| Feedback PLC (FDBK) | $1.11 Million | -163.58% | 1.04x | $679.70 |
| Induction Healthcare Group PLC (INHC) | $16.47 Million | -46.24% | 0.22x | $1.11K |
| Kooth plc (KOO) | $-744.53K | 0.00% | 0.00x | $5.37K |
| Optima Health plc (OPT) | $126.31 Million | -0.19% | 0.52x | $19.71K |